Pharmaceuticals

HCmed Innovations joins Wuxi International Life Science Innovation Park supported by AstraZeneca China

TAIPEI, Sept. 7, 2019 /PRNewswire/ -- Supported by the idea of garnering global wisdom to improve the healthcare system inChina, Wuxi Municipal Government, Wuxi High-tech District, and AstraZeneca, as a founding partner, officially inaugurated Wuxi International Life Science Innovation Park onSep...

2019-09-07 18:30 891

CARsgen Therapeutics Receives US FDA Orphan Drug Designation For Fully Human Anti-BCMA (B Cell Maturation Antigen) Autologous Chimeric Antigen Receptor (CAR) T Cells For The Treatment Of Multiple Myeloma

SHANGHAI, Aug. 30, 2019 /PRNewswire/ -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investigational CAR-T cell therapy fully human anti-BCMA (B Cell Maturation...

2019-08-31 10:54 1938

Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- Luye Pharma Group (02186.HK) released its financial results for the first half of 2019 onAugust 28. The results show the company has achieved a revenue ofRMB 3.131 billion, up 42.1% year-on-year; EBITDA reachedRMB 1.263 billion, up 44.1% year-on-year, while...

2019-08-29 16:34 11063

Taiho Pharmaceutical Invests in New Venture Capital Fund

TOKYO, Aug. 29, 2019 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director:Masayuki Kobayashi) announced on August 29 that the company has entered into an agreement to invest up toUS$30 million in Remiges Biopharma Fund II, LP a biopharma venture capital...

2019-08-29 13:00 1365

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Texas

The procedure was performed by Joseph M. Berman, MD, an orthopedic surgeon at Arlington Orthopedics Associates (AOA),Arlington, TX KFAR SABA, Israel, Aug. 27, 2019 /PRNewswire/ — CartiHeal , developer of Agili-C™, a proprietary implant for the treatment of cartilage le...

2019-08-27 22:24 1329

Regulation Needs to Keep Pace With Global Cannabis Legalisation in 2019 - Prohibition Partners

LONDON, Aug. 22, 2019 /PRNewswire/ -- The number of countries to legalise medical cannabis has risen nine-fold in the last five years, as global attitudes towards cannabis have shifted in favour of liberalisation. In 2019, 43 countries have legalised medical cannabis, with a host more allowing p...

2019-08-22 19:54 1489

CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting

SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201...

2019-08-20 10:18 3724

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today annou...

2019-08-19 20:00 7260

Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress

SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annua...

2019-08-19 13:50 4112

China Pharma Holdings, Inc. Reports Second Quarter 2019 Financial Results

HAIKOU, China, Aug. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...

2019-08-15 18:30 7480

CStone Pharmaceuticals Reports First Half 2019 Financial Results

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and molecularly-targeted drugs for the treatment of cancer, today released its recent business ...

2019-08-15 15:31 5189

China Jo-Jo Drugstores Reports First Quarter 2020 Financial Results

HANGZHOU, China, Aug. 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider inChina, today announced i...

2019-08-14 21:00 6687

CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study

SUZHOU, China, Aug. 13, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announces the dosing of the first patient inChina for the Phase I registrational study of BLU-667, which was discovered by the company's partner Blueprint Medicines. This clinical trial is a part of t...

2019-08-13 12:21 6261

China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate

TAIZHOU, China, Aug. 12, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced to...

2019-08-12 20:00 6374

EnGeneIC Wins Innovation Award from Australian Financial Review

Named Most Innovative Healthcare Company of 2019 for its Nanocell Platform for Targeted Cyto-Immunotherapy in Cancer Treatment NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targe...

2019-08-09 12:49 1242

CStone to Build Global R&D Headquarters and Industrialization Base in the Suzhou Industrial Park

SUZHOU, China, Aug. 7, 2019 /PRNewswire/ -- The signing ceremony for CStone Pharmaceuticals' ("CStone") (HKEX: 2616) Global R&D Headquarters and Industrialization Base ("the Project") took place in Suzhouon August 6. The event marks the building of yet another state-of-the-art research and devel...

2019-08-07 14:47 6975

China Biologic Reports Financial Results for the Second Quarter of 2019

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to$41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms-- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to$79.3 Million; Non-GAA...

2019-08-06 04:30 7460

New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients

MELBOURNE, Australia and ATLANTA, Aug. 5, 2019 /PRNewswire/ -- Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect. The Therapeutic Goods Administration has now approved the drug IL...

2019-08-05 20:00 1269

I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors

SHANGHAI and SAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China and U.S.-based clinical stage biopharmaceutical company exclusively focused on the discovery and development of potential first-in-class and best-in-class biologics in immuno-oncology and autoimmune diseases, an...

2019-08-01 20:06 1563

111 to Announce Second Quarter 2019 Unaudited Financial Results on August 15, 2019

SHANGHAI, Aug. 1, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the second quarter endedJune 30, 2019, before U.S. markets open o...

2019-08-01 20:00 5811
123456 ... 40